Dr.Zygmet Pharma Private Limited - Company Profile

It is a chemicals private limited company based in Hyderabad., Telangana, India, established in 2003.
2003 Hyderabad., Telangana, India Struck Off
Last Updated:
Access Report
About Dr.Zygmet Pharma Private Limited

Dr.Zygmet Pharma Private Limited, a struck off private limited company, was established on 05 May 2003 in Hyderabad., Telangana, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24239TG2003PTC040946. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

Its leadership includes Siddharth Singh Thakur (Director), Mahati Singh (Director). Past directors included Seethalakshmi Yeddanapudi. Its latest AGM occurred on 30 September 2010, with the balance sheet filed on 31 March 2010. It is based at 7-147/1,Nagendra Nagar Colony Habsiguda,, Hyderabad., Telangana, 500007.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239TG2003PTC040946

  • Registration Number

    040946

  • Incorporation Date

    05 May 2003

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 22 Year, 9 Months
  • Last Filing with ROC 31 Mar 2010
Company report

Dr.Zygmet Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Dr.Zygmet Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Dr.Zygmet Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Siddharth Singh Thakur Director 30 Oct 2009 Current
Mahati Singh Director 05 May 2003 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 04 Nov 2009 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Dr.Zygmet Pharma.

Enhance accessibility to Dr.Zygmet Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Dr.Zygmet Pharma revenue growth over time
Dr.Zygmet Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Dr.Zygmet Pharma?

Unlock access to Dr.Zygmet Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Dr.Zygmet Pharma?

Unlock and access historical data on people associated with Dr.Zygmet Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Dr.Zygmet Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr.Zygmet Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Dr.Zygmet Pharma
Recent Activity within the Organization
  • Annual General Meeting

    The activity Dr.Zygmet Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2010 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Dr.Zygmet Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2010 with Roc Hyderabad. was documented.

  • Director Appointment

    Progress on Siddharth Singh Thakur was appointed as a Director was appointed as a Director on 30 Oct 2009 & has been associated with this company since 16 years 3 months . was documented.

  • Director Appointment

    The activity Mahati Singh was appointed as a Director was appointed as a Director on 05 May 2003 & has been associated with this company since 22 years 9 months . was completed.

  • Company Incorporation

    Progress on Dr.Zygmet Pharma Private Limited was registered on 05 May 2003 with Roc Hyderabad & aged 22 years 9 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Dr.Zygmet Pharma Private Limited?

The CIN of Dr.Zygmet Pharma Private Limited is U24239TG2003PTC040946.

Where is Dr.Zygmet Pharma Private Limited headquartered?

Dr.Zygmet Pharma Private Limited is headquartered at 7-147/1,Nagendra Nagar Colony Habsiguda,, Hyderabad., Telangana, 500007.

When was Dr.Zygmet Pharma Private Limited incorporated?

Dr.Zygmet Pharma Private Limited was incorporated on 05 May 2003.

Who are the current directors of Dr.Zygmet Pharma Private Limited?

The current directors of Dr.Zygmet Pharma Private Limited are

What is the primary industry of Dr.Zygmet Pharma Private Limited?

The primary industry of Dr.Zygmet Pharma Private Limited is Chemicals.

Is Dr.Zygmet Pharma Private Limited a listed company?

Dr.Zygmet Pharma Private Limited is unlisted.

What is the capital structure of Dr.Zygmet Pharma Private Limited?

The authorized capital of Dr.Zygmet Pharma Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available